ChemicalBook > CAS DataBase List > GTQTUABHRCWVLL-UHFFFAOYSA-N

GTQTUABHRCWVLL-UHFFFAOYSA-N

Product Name
GTQTUABHRCWVLL-UHFFFAOYSA-N
CAS No.
1383450-81-4
Chemical Name
GTQTUABHRCWVLL-UHFFFAOYSA-N
Synonyms
JNJ-678);Rilematovir;Rilematovir (JNJ-678);JNJ-678 (JNJ-53718678);JNJ-53718678 (JNJ53718678;Rilematovir, 10 mM in DMSO;GTQTUABHRCWVLL-UHFFFAOYSA-N;Rilematovir (Synonyms: JNJ-678;GTQTUABHRCWVLL-UHFFFAOYSA-N,JNJ-53718678;3-((5-Chloro-1-(3-(methylsulfonyl)propyl)-1H-indol-2-yl)methyl)-1-(2,2,2-trifluoroethyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one
CBNumber
CB83147021
Molecular Formula
C21H20ClF3N4O3S
Formula Weight
500.92
MOL File
1383450-81-4.mol
More
Less

GTQTUABHRCWVLL-UHFFFAOYSA-N Property

Boiling point:
672.5±55.0 °C(Predicted)
Density 
1.50±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:65.0(Max Conc. mg/mL);129.76(Max Conc. mM)
form 
A crystalline solid
pka
6.39±0.20(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0043622
Product name
JNJ-678
Purity
98.22%
Packaging
5mg
Price
$450
Updated
2021/12/16
ChemScene
Product number
CS-0043622
Product name
JNJ-678
Purity
98.22%
Packaging
10mg
Price
$750
Updated
2021/12/16
ChemScene
Product number
CS-0043622
Product name
JNJ-678
Purity
98.22%
Packaging
25mg
Price
$1500
Updated
2021/12/16
ChemScene
Product number
CS-0043622
Product name
JNJ-678
Purity
98.22%
Packaging
50mg
Price
$2100
Updated
2021/12/16
ChemScene
Product number
CS-0043622
Product name
JNJ-678
Purity
98.22%
Packaging
100mg
Price
$3300
Updated
2021/12/16
More
Less

GTQTUABHRCWVLL-UHFFFAOYSA-N Chemical Properties,Usage,Production

Uses

Rilematovir (JNJ-678) is a novel fusion protein inhibitor. Rilematovir has the potential for respiratory syncytial virus (RSV) research.

in vivo

Oral treatment of neonatal lambs with Rilematovir, or with an equally active close analog, efficiently inhibits established acute lower respiratory tract infection in the animals, even when treatment is delayed until external signs of respiratory syncytial virus illness have become visible[1].

References

[1] Roymans D, et al. Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. Nat Commun. 2017 Aug 1;8(1):167. DOI:10.1038/s41467-017-00170-x

GTQTUABHRCWVLL-UHFFFAOYSA-N Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GTQTUABHRCWVLL-UHFFFAOYSA-N Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81

1383450-81-4, GTQTUABHRCWVLL-UHFFFAOYSA-NRelated Search:


  • GTQTUABHRCWVLL-UHFFFAOYSA-N
  • JNJ-53718678 (JNJ53718678
  • JNJ-678)
  • 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one
  • 2H-Imidazo[4,5-c]pyridin-2-one, 3-[[5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl]methyl]-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
  • JNJ-678 (JNJ-53718678)
  • GTQTUABHRCWVLL-UHFFFAOYSA-N,JNJ-53718678
  • Rilematovir (Synonyms: JNJ-678
  • 3-((5-Chloro-1-(3-(methylsulfonyl)propyl)-1H-indol-2-yl)methyl)-1-(2,2,2-trifluoroethyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one
  • Rilematovir
  • Rilematovir (JNJ-678)
  • Rilematovir, 10 mM in DMSO
  • 1383450-81-4
  • C21H20ClF3N4O3S